Access cutting-edge pleural mesothelioma treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access pleural mesothelioma specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pleural mesothelioma treatment provided free
This is a phase III, randomized, open-label, multicenter, global study to determine the efficacy and safety of Volrustomig (MEDI5752) + Carboplatin + Pemetrexed vs the investigator's choice of platinum + Pemetrexed or Nivolumab + Ipilimumab in participants with unresectable pleural mesothelioma.
Sponsor: AstraZeneca
Check if you qualify for this pleural mesothelioma clinical trial in Chicago, IL
If you're searching for pleural mesothelioma treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pleural mesothelioma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.